课题基金 / 基金详情

Automated and sensitive genomic co-profiling for precision pharmacogenomics

Automated and sensitive genomic co-profiling for precision pharmacogenomics
用于精准药物基因组学的自动化、灵敏的基因组共同分析
批准号:
9303306
负责人:
Paul Clark Blainey
金额:
$13.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-06-24 至 2017-08-15

项目摘要

项目成果

Paul Clark Blainey的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract Genomics methods like expression profiling and epigenomic profiling hold enormous potential benefit to parse the effects of drugs and assess patient response to therapy in the clinic. However, the lack of advanced sample preparation methods is a blocking issue in translating informative genomic techniques for application in chemical biology and clinical medicine. Even advanced single-cell genomics methods require large total input quantities and struggle to produce more than one type of genomic profile, which may not be sufficiently informative or predictive. Powerful computational tools to integrate multiple layers of `omic information are available and ready to accept data if available from the right samples. Thus, the need to prepare multiple sequence library types at the same time (eg co-profiling epigenome and transcriptome) from small numbers of primary cells in a single streamlined system is a crucial missing link in the advancement of chemical biology and realizing the potential impact of genomic medicine. The proposed project will solve this sample preparation challenge by establishing simultaneous epigenomic and expression co-profiling sample preparation method from low biomass samples in an automated microfluidic device. The co-profiling sample preparation system will constitute a single microdevice able to accept small multiple primary cell samples and automatically produce multiple sequence library types in a single run. We will apply this capability to dissect the pleiotropic effects of an important new drug class, histone deacetylase inhibitors (HDACi). HDACi have (currently) unpredictable effects on gene activity, but show promise for therapeutic modulation of proliferative, inflammatory, autoimmune, and neurological processes. To evaluate potential therapeutic effects and safety (regarding immunity to infection) of HDACi treatment, we will co-profile HDACi-treated human primary cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting Dysregulated RNA Splicing in Neurodegenerative Diseases
  • 批准号:
    10729566
  • 项目类别:
  • 资助金额:
    $207.29万
  • 财政年份:
    2023
  • 负责人:
    Paul Clark Blainey
  • 依托单位:
Stitch-seq for genome-wide pooled genomic screening with RNA-seq readout
  • 批准号:
    10413630
  • 项目类别:
  • 资助金额:
    $20.78万
  • 财政年份:
    2022
  • 负责人:
    Paul Clark Blainey
  • 依托单位:
Stitch-seq for genome-wide pooled genomic screening with RNA-seq readout
  • 批准号:
    10620301
  • 项目类别:
  • 资助金额:
    $16.73万
  • 财政年份:
    2022
  • 负责人:
    Paul Clark Blainey
  • 依托单位:
Innovative technologies to transform antibiotic discovery. Project 2 Engineering antibiotic sensitization therapies
  • 批准号:
    10463689
  • 项目类别:
  • 资助金额:
    $168.76万
  • 财政年份:
    2019
  • 负责人:
    Paul Clark Blainey
  • 依托单位:
海外基金